Gentel plans to add 50 new kits to its product portfolio by the end of the year, as it transforms itself from being a services-oriented business to one that derives the bulk of its sales from products.
The collaboration covers Protein Biotechnologies' SomaPlex arrays and Gentel Bioscience's APiX View Detection Kits, which were launched this week.
Illumina's VeraCode ADME Core Panel, Aushon Biosystems' human vascular injury panels, BioServe and Protein Biotechnologies' SomaPlex reverse-phase protein microarrays
The SomaPlex Reverse Phase Protein Microarray is the first product stemming from a collaboration between the two firms, and additional arrays are planned for launch throughout 2010.
Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.
Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.
In Science this week: research regulation and reporting requirement reform, and more.
With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.